A mineral produced by plate tectonics has a global cooling effect, study finds

A mineral produced by plate tectonics has a global cooling effect, study finds

MIT geologists have found that a clay mineral on the seafloor, called smectite, has a surprisingly powerful ability to sequester carbon over millions of years.

Under a microscope, a single grain of the clay resembles the folds of an accordion. These folds are known to be effective traps for organic carbon.

Now, the MIT team has shown that the carbon-trapping clays are a product of plate tectonics: When oceanic crust crushes against a continental plate, it can bring rocks to the surface that, over time, can weather into minerals including smectite. Eventually, the clay sediment settles back in the ocean, where the minerals trap bits of dead organisms in their microscopic folds. This keeps the organic carbon from being consumed by microbes and expelled back into the atmosphere as carbon dioxide.

Over millions of years, smectite can have a global effect, helping to cool the entire planet. Through a series of analyses, the researchers showed that smectite was likely produced after several major tectonic events over the last 500 million years. During each tectonic event, the clays trapped enough carbon to cool the Earth and induce the subsequent ice age.

The findings are the first to show that plate tectonics can trigger ice ages through the production of carbon-trapping smectite.

These clays can be found in certain tectonically active regions today, and the scientists believe that smectite continues to sequester carbon, providing a natural, albeit slow-acting, buffer against humans’ climate-warming activities.

“The influence of these unassuming clay minerals has wide-ranging implications for the habitability of planets,” says Joshua Murray, a graduate student in MIT’s Department of Earth, Atmospheric, and Planetary Sciences. “There may even be a modern application for these clays in offsetting some of the carbon that humanity has placed into the atmosphere.”

Murray and Oliver Jagoutz, professor of geology at MIT, have published their findings today in Nature Geoscience.

A clear and present clay

The new study follows up on the team’s previous work, which showed that each of the Earth’s major ice ages was likely triggered by a tectonic event in the tropics. The researchers found that each of these tectonic events exposed ocean rocks called ophiolites to the atmosphere. They put forth the idea that, when a tectonic collision occurs in a tropical region, ophiolites can undergo certain weathering effects, such as exposure to wind, rain, and chemical interactions, that transform the rocks into various minerals, including clays.

“Those clay minerals, depending on the kinds you create, influence the climate in different ways,” Murray explains.

At the time, it was unclear which minerals could come out of this weathering effect, and whether and how these minerals could directly contribute to cooling the planet. So, while it appeared there was a link between plate tectonics and ice ages, the exact mechanism by which one could trigger the other was still in question.

With the new study, the team looked to see whether their proposed tectonic tropical weathering process would produce carbon-trapping minerals, and in quantities that would be sufficient to trigger a global ice age.

The team first looked through the geologic literature and compiled data on the ways in which major magmatic minerals weather over time, and on the types of clay minerals this weathering can produce. They then worked these measurements into a weathering simulation of different rock types that are known to be exposed in tectonic collisions.

“Then we look at what happens to these rock types when they break down due to weathering and the influence of a tropical environment, and what minerals form as a result,” Jagoutz says.

Next, they plugged each weathered, “end-product” mineral into a simulation of the Earth’s carbon cycle to see what effect a given mineral might have, either in interacting with organic carbon, such as bits of dead organisms, or with inorganic, in the form of carbon dioxide in the atmosphere.

From these analyses, one mineral had a clear presence and effect: smectite. Not only was the clay a naturally weathered product of tropical tectonics, it was also highly effective at trapping organic carbon. In theory, smectite seemed like a solid connection between tectonics and ice ages.

But were enough of the clays actually present to trigger the previous four ice ages? Ideally, researchers should confirm this by finding smectite in ancient rock layers dating back to each global cooling period.

“Unfortunately, as clays are buried by other sediments, they get cooked a bit, so we can’t measure them directly,” Murray says. “But we can look for their fingerprints.”

A slow build

The team reasoned that, as smectites are a product of ophiolites, these ocean rocks also bear characteristic elements such as nickel and chromium, which would be preserved in ancient sediments. If smectites were present in the past, nickel and chromium should be as well.

To test this idea, the team looked through a database containing thousands of oceanic sedimentary rocks that were deposited over the last 500 million years. Over this time period, the Earth experienced four separate ice ages. Looking at rocks around each of these periods, the researchers observed large spikes of nickel and chromium, and inferred from this that smectite must also have been present.

By their estimates, the clay mineral could have increased the preservation of organic carbon by less than one-tenth of a percent. In absolute terms, this is a miniscule amount. But over millions of years, they calculated that the clay’s accumulated, sequestered carbon was enough to trigger each of the four major ice ages.

“We found that you really don’t need much of this material to have a huge effect on the climate,” Jagoutz says.

“These clays also have probably contributed some of the Earth’s cooling in the last 3 to 5 million years, before humans got involved,” Murray adds. “In the absence of humans, these clays are probably making a difference to the climate. It’s just such a slow process.”

“Jagoutz and Murray’s work is a nice demonstration of how important it is to consider all biotic and physical components of the global carbon cycle,” says Lee Kump, a professor of geosciences at Penn State University, who was not involved with the study. “Feedbacks among all these components control atmospheric greenhouse gas concentrations on all time scales, from the annual rise and fall of atmospheric carbon dioxide levels to the swings from icehouse to greenhouse over millions of years.”

Could smectites be harnessed intentionally to further bring down the world’s carbon emissions? Murray sees some potential, for instance to shore up carbon reservoirs such as regions of permafrost. Warming temperatures are predicted to melt permafrost and expose long-buried organic carbon. If smectites could be applied to these regions, the clays could prevent this exposed carbon from escaping into and further warming the atmosphere.

“If you want to understand how nature works, you have to understand it on the mineral and grain scale,” Jagoutz says. “And this is also the way forward for us to find solutions for this climatic catastrophe. If you study these natural processes, there’s a good chance you will stumble on something that will be actually useful.”

This research was funded, in part, by the National Science Foundation.

How to Turn Your Corporate Space into an NDI Studio: NDI November – Be – Videoguys

On this Videoguys Live, James, our video production specialist, shares insights on the successful execution of our month-long event, NDI November. Discover the secrets behind transforming any corporate space into an NDI studio, empowering you to host your own engaging virtual events. James will walk you through key considerations, from audience analysis and brand incorporation to the selection of hardware and software for a seamless live stream. Learn valuable tips on using platforms like Crowdcast for scheduling and interactivity, and explore tools such as Vizrt Flowics for captivating graphics. Whether you’re a seasoned content creator or a novice in the virtual event space, this session provides actionable guidance to elevate your live streaming experience.

[embedded content]


Topics To Go Over Today:

  1. Determine your audience
  2. Incorporate your brand
  3. Hardware We used
  4. Remote contribution

Determine Your Audience:
Things to consider:​

  • How will the audience watch?​
  • What time will your show be?​
  • Will they have to register, or will it be open to public?​
  • Do you want interactivity?

We Decided To Use CrowdCast

How to Turn Your Corporate Space into an NDI Studio: NDI November – Be – Videoguys

Incorporate Your Brand
Regardless of if you’re a school, House of Worship, or Corporate office you want to incorporate your brand.​
Incorporate things such as:​

  • Logo Bugs​
  • Lower thirds​
  • Virtual sets​
  • Live sets​
  • B-roll​
  • Keep it consistent!​

Lower Thirds

  • Informational Clarity:​ Lower thirds ensure quick viewer comprehension by displaying speaker names, titles, or key details, minimizing disruptions to the main content.​
  • Branding and Professionalism:​ Consistent branding in lower thirds enhances livestream professionalism, reinforcing brand identity for a polished and memorable viewer experience.​
  • Contextual Updates:​ Real-time updates and announcements through lower thirds keep viewers informed without interrupting the livestream’s flow, ensuring engagement.​
  • Audience Engagement:​ Lower thirds with social media handles and calls-to-action encourage audience interaction, extending the livestream’s reach and enhancing its social aspect.​

Virtual Events:

  • Lighting Consistency:​ Ensure even and consistent lighting on the green screen to avoid shadows or uneven color, enabling seamless integration with virtual sets.​
  • Appropriate Attire and Colors:​ Choose clothing that contrasts with the green screen, avoiding colors similar to the background, and consider the overall color scheme of the virtual set for better visual harmony.​
  • Camera Placement and Distance:​ Position the camera correctly to maintain perspective and keep an appropriate distance from the green screen to minimize spillage and facilitate effective keying.​
  • Avoid Reflective Surfaces:​ Minimize reflective surfaces in the green screen area to prevent unwanted reflections, which can complicate the keying process and impact the realism of the virtual set.​

Our Studio Workflow

 Remote Contribution
Ways to have Guests join​

  • Live Remote Guest :​ A guest joins Live remotely as your stream is going​
  • Live in Person​: A guest joins in studio Live.​
  • Record as Live​: A Guest cannot make the live event, so you pre record in advance as if it were live.​
  • Pre-Produced​: This can be something such as a commercial the guest makes, or a joint effort. ​

The League Of Upcoming Superhero Games

The League Of Upcoming Superhero Games

Motive Studio, the team behind Star Wars: Squadrons and the Dead Space remake, has an untitled Iron Man game in the works. This third-person, single-player action game aims to capture, per Motive, “the complexity, charisma, and creative genius of Tony Stark, enabling players to feel what it’s like to truly play as Iron Man.” The game’s line-up includes executive producer Olivier Proulx, who served as producer on the well-received Marvel’s Guardians of the Galaxy. Motive announced the game as being in pre-production, meaning it will likely be a long while before we see any actual footage of it. Iron Man will also be the first game of a longer partnership between EA and Marvel. 

Immune action at a distance

Immune action at a distance

For most metastatic cancer types, there are no reliably effective treatments. Therapies may slow the growth of tumors, but they will not eradicate them. Occasionally, however, treating a tumor in one location will cause untreated tumors elsewhere in the body to shrink or even regress completely — a dramatic but exceedingly rare phenomenon known as the abscopal effect.

Cancer researchers have sought methods to induce the abscopal effect by design. The abscopal effect is thought to arise when dead or damaged tumor cells release antigens that teach some types of immune cells to recognize and attack other and even distant cancer cells. Essentially, the treated tumor behaves like a personalized cancer vaccine that incites the immune system to attack metastasized tumors. The advent of cancer immunoadjuvants, which enhance and sustain the activity of tumor-targeting immune cells, has been a key to unlocking the abscopal effect, at least in the laboratory setting. 

In the clinic, success has proven more elusive. Since immunotherapies can lead to serious toxicities if administered through the bloodstream, they must be delivered directly to the tumor — often by injection. It is difficult for clinicians to target injections precisely to the tumor and impossible to confirm delivery. Once injected, immunostimulatory drugs quickly leak out of the tumor before they have had a chance to take full effect.

MIT researchers, together with colleagues from Mass General Brigham, have developed a polymer gel delivery system that could help translate the promise of the abscopal effect into the clinic. The gel, visible with a CT scanner or ultrasound, solidifies after injection, where it remains in the tumor to release drugs at a controlled rate.

In a study published in Advanced Healthcare Materials, the team delivered the immune-stimulating drug imiquimod in combination with checkpoint blockade therapy to dual-tumor mouse models of colon and breast cancer, which showed improved survival as well as tumor regression in both treated and untreated tumors.

“The field has been seeking the ‘holy grail’ of the abscopal effect for the past 15 years,” says Giovanni Traverso, a senior author of the study, Karl Van Tassel Career Development Professor in the Department of Mechanical Engineering, and a member of the Koch Institute for Integrative Cancer Research at MIT. “Now, with drug-delivery materials better adapted for the clinic, it could be within reach.”

Traverso’s co-senior author is Umar Mahmood, director of the Center for Precision Imaging and chief of the Division of Nuclear Medicine and Molecular Imaging at Massachusetts General Hospital (MGH). Avik Som, interventional and diagnostic radiology resident at MGH; Jan-Georg Rosenboom, senior postdoc in the Langer and Traverso labs at the Koch Institute; and  Eric Wehrenberg-Klee, director of the Center for Image-Guided Cancer Therapy and assistant professor at Harvard Medical School, are co-lead authors. Robert Langer, David H. Koch Institute Professor, is also an author of the study.

Defining the problem

At MGH, clinicians saw that of 18 patients that were treated with an intratumoral injection of immunotherapy either just before or after undergoing a procedure known as cryoablation, one patient with metastatic melanoma showed a sustained abscopal effect. In cryoablation, a tumor is injected with freezing gas and then thawed out, with the hope of inducing a system-wide immune response to tumors.

The observation pointed to a promising avenue for achieving the abscopal effect for more patients, but a new tool was needed to address some of the realities of intratumoral injections in the clinic. In addition to the difficulties of delivering intratumoral injections for the clinician, these treatments are costly and infeasible for patients. Because tumors do not retain immunotherapies for long, patients require repeat injections — with sedation — over several days. The clinicians looked across the river to their MIT colleagues for help.

 “My clinical colleagues came to us with this very interesting problem, so we thought, how can we address this from our own chemical engineering perspective?” says Rosenboom.

The interdisciplinary team determined that the injected material would need to be liquid at room temperature during injection, and then solidify once inside the tumor to prevent leakage. For optimal drug delivery, the gel would need to carry a high concentration of drug in a small volume and then release its payload in a controlled fashion over several days. The team planned to add an iodinated and clinically approved contrast agent to make it visible with a CT scan to help clinicians confirm they have successfully injected the material. To help smooth the path of the platform to the clinic, the gel should be known to be safe and biocompatible and the immunotherapy it transports to have proven effectiveness.

“As a radiologist, I can see tumors under CT or ultrasound, but I can’t see the drugs they are asking me to inject!” says Som. “That’s why we designed a formulation for a promising immunoadjuvant that could be image guided by both modalities. This platform should hopefully realize the immense promise of personalized cancer vaccines.”

Adds Wehrenberg-Klee, “When developing new intratumoral immunotherapies, being able to confirm delivery into tumor is a critical variable. Intratumoral immunotherapy relies on the assumption that you are delivering therapy to tumor, but our clinical experience suggests this may not always be true. If we can see what we’ve injected, we can eliminate that concern.”

“As engineers, we needed to solve the problem of how to tune a polymer formulation to achieve injectability, solidification at body temperature, prolonged drug release, and visibility — all at the same time, all while these properties affect one another,” says Rosenboom. “That took us about four years to figure out.”

A solution gels

After investigating several polymers, the researchers found that a three-part polymer called PLGA-PEG-PLGA would help them balance the several competing features required of their platform. The polymer is thermosensitive. With slight changes to its molecular weight (size), it can be adjusted to be liquid at room temperature during injection and more viscous in the warmer environment of the tumor.

The polymer is also amphiphilic, with a PEG block that is attracted to water and two PLGA blocks that repel water, so that it forms a nanoparticle around the hydrophobic drug. Its amphiphilic properties allow its drug-release behaviors to be precisely tuned: the more hydrophobic the PLGA block, the slower the release. The formulation allowed a slowed drug release over four to five days, which was a timeframe previously reported to be effective when injected daily.

A similar version of the polymer has already been studied in clinical trials for delivering a type of chemotherapy, paclitaxel. However, in this scenario, the gel would transport imiquimod, an immunotherapy already approved by the Food and Drug Administration (FDA) that is commonly used topically to treat basal cell carcinoma.

Once the gel had been tailored to meet their requirements, the team tested it in mouse models of colon and breast cancer that are usually resistant to immunotherapy. In combination with a type of immunotherapy called checkpoint blockade therapy, they used the platform to deliver imiquimod. Each mouse had two tumors of the same type, but only one tumor was treated. If both tumors regressed, then the researchers could confirm their platform could induce a system-wide immune response to tumors — the abscopal effect.

Overall, the combination of checkpoint blockade therapy and intratumorally delivered imiquimod resulted in improved survival in both colon and breast cancer models. The treatment resulted in an all-or-nothing response, with complete regression of both the treated and untreated tumors in the mice that did respond to therapy. For nonresponders, there was no regression in either tumor. The researchers also tested the combination therapy of gel-delivered imiquimod and checkpoint blockade therapy with and without cryoablation of the treated tumor and found that the two approaches gave similar results.

Because the platform is made from safe materials to deliver an already-approved drug, the team expects that the path to FDA approval will be significantly shorter than for completely novel platforms and therapies. The team is also working with industry partners to adapt the platform for treating other tumor types and to deliver other therapies.

This study was funded in part by a Philips RSNA Research Award, a Schlaeger Research Fellowship, a postdoctoral fellowship from the Ludwig Center at the Koch Institute, and grants from Boston Scientific, the MIT Deshpande Center for Technological Innovation, and the National Cancer Institute.

Ampere Computing: Unlocking a Path to the Sustainable Cloud – AI News

AI News caught up with Victor Jakubiuk, Head of AI at Ampere Computing, a semiconductor company offering Cloud Native Processors. We discussed how they are driving high-performance, scalable and energy-efficient solutions built for the sustainable cloud. In today’s business landscape, artificial intelligence (AI) has been an…